Trisalus Strengthens Infusion System Growth with $50M Debt Financing
TriSalus Life Sciences recently secured a $50 million debt facility from OrbiMed. This financing aims to support TriSalus’ expansion...
Walmart Health Center Exit: Is It Good For Clinical Trials?
This article contains speculative content, opinions, and assumptions about the Walmart Health center that are not confirmed facts. The...
c2n Diagnostics partners with Mediford for Precivity™ Alzheimer’s Blood Test Expansion in Japan
C2N Diagnostics has partnered with Mediford Corporation, a subsidiary of PHC Holdings, to enhance access to its clinical research...
Biktarvy® Label Update: Hopeful News for Pregnant Adults with HIV
The U.S. Food and Drug Administration (FDA) has approved an updated label for Biktarvy, extending its safety and efficacy...
FDA Approves Pfizer’s Gene Therapy Treatment for Hemophilia B
Pfizer’s BEQVEZ, a one-time gene therapy, has received FDA approval for treating adults with moderate to severe hemophilia B....
Tivdak’s Full FDA Approval: A Triumphant Victory for Metastatic Cervical Cancer Treatment
The U.S. Food and Drug Administration (FDA) has granted full approval to TIVDAK (tisotumab vedotin-tftv) for the treatment of...
Merck’s V116 Vaccine: A Revolutionary Breakthrough for Adult Pneumococcal Protection
A Phase 3 trial (STRIDE-10) evaluated V116, a 21-valent pneumococcal conjugate vaccine, in adults over 50. The study compared...
Enhancing Data Integrity: New Clinical Trial Imaging Techniques
In this interview, Jeffrey Sorenson, CEO of Yunu, outlines how his company is enhancing the precision and efficiency of...
Taking Stock of Obesity Drug Development: Trends and Challenges Facing Today’s Researchers
Rising levels of obesity have become a global health issue, with an estimated 2.8 million people dying each year...
RBQM Technology Trends: Shaping the Future of Clinical Trials
In the evolving field of clinical trials, Risk-Based Quality Management (RBQM) emerges as a cornerstone for enhancing trial efficiency...